Positive selection of hepatitis delta antigen in chronic hepatitis D patients

Journal of Virology

Volumn 81, Issue 9, 2007, Pages 4438-4444

  Wang, Shen Yung ^a,c   Wu, Jaw Ching ^a,b   Chiang, Tzen Yuh ^d   Huang, Yi Hsiang ^a,b   Su, Chien Wei ^a,b   Sheen, I Jane ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINOTRANSFERASE; EPITOPE; HEPATITIS DELTA ANTIGEN; VACCINE;

AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY COMBINING SITE; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DELTA AGENT HEPATITIS; DISEASE COURSE; DRUG TARGETING; GENETIC VARIABILITY; GENOTYPE; HEPATITIS DELTA VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENIC DOMAIN; IMMUNOGENICITY; LIGAND BINDING; LIKELIHOOD RATIO TEST; MAXIMUM LIKELIHOOD METHOD; NEURAL NETWORK METHOD; NUCLEOTIDE SEQUENCE; POSITIVE SELECTION; PRIORITY JOURNAL; SUPERINFECTION; TECHNIQUE; VIRAL GENETICS; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; HEPATITIS D, CHRONIC; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; LIKELIHOOD FUNCTIONS; MOLECULAR SEQUENCE DATA; NEURAL NETWORKS (COMPUTER); PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA;

HEPATITIS DELTA VIRUS;

EID: 34247564231     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02847-06     Document Type: Article

References (33)

1. Accapezzato, D., R. Nisini, M. Paroli, G. Bruno, F. Bonino, M. Houghton, and V. Barnaha. 1998. Generation of an MHC class II-restricted T-cell epitope by extracellular processine of hepatitis delta antigen. J. Immunol. 160:5262-5266.
2. Anisimova, M., and Z. Yang. 2004. Molecular evolution of the hepatitis delta virus antigen gene: recombination or positive selection? J. Mol. Evol. 59: 815-826.
3. Chang, J., S. O. Gudima, and J. M. Taylor. 2005. Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture. J. Virol. 79:13310-13316.
4. Chao, Y. C., C. M. Lee, H. S. Tang, S. Govindarajan, and M. M. Lai. 1991. Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology 13:345-352.
5. Chung, C. T., and R. H. Miller. 1988. A rapid and convenient method for the preparation and storage of competent bacterial cells. Nucleic Acids Res. 16:3580.
6. Cole, S. M., E. J. Gowans, T. B. Macnaughton, P. D. Hall, and C. J. Burrell. 1991. Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology 13:845-851.
7. Govindarajan, S., K. P. Chin, A. G. Redeker, and R. L. Peters. 1984. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 86:1417-1420.
8. + T cells with viral clearance in acute hepatitis C. J. Infect. Dis. 181: 1528-1536.
9. Hadler, S. C., M. De Monzon, A. Ponzetto, E. Anzola, D. Rivero, A. Mondolfi, A. Bracho, D. P. Francis, M. A. Gerber, S. Thung, et al. 1984. Delta virus infection and severe hepatitis: an epidemic in the Yucpa Indians of Venezuela. Ann. Intern. Med. I00:339-344.
10. + T-cell epitopes on hepatitis delta virus. J. Gen. Virol. 85:3089-3098.
11. Huang, Y. H., J. C. Wu, S. C. Hsu, and W. J. Syu. 2003. Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens. J. Virol. 77:12980-12985.
12. Krushkal, J., and W. H. Li. 1995. Substitution rates in hepatitis delta virus. J. Mol. Evol. 41:721-726.
13. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
14. Modahl, L. E., and M. M. Lai. 2000. Hepatitis delta virus: the molecular basis of laboratory diagnosis. Crit. Rev. Clin. Lab. Sci. 37:45-92.
15. Nielsen, M., C. Lundegaard, P. Worning, S. L. Lauemoller, K. Lamberth, S. Buus, S. Brunak, and O. Lund. 2003. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12:1007-1017.
16. + T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J. Virol. 71:2241-2251.
17. Ottobrelli, A., A. Marzano, A. Smedile, S. Recchia, M. Salizzoni, C. Cornu, M. E. Lamy, J. B. Otte, B. De Hemptinne, A. Geubel, et al. 1991. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 101:1649-1655.
18. Radjef, N., E. Gordien, V. Ivaniushina, E. Gault, P. Anais, T. Drugan, J. C. Trinchet, D. Roulot, M. Tamby, M. C. Milinkovitch, and P. Deny. 2004. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J. Virol. 78:2537-2544.
19. Rizzetto, M., M. G. Canese, J. L. Gerin, W. T. London, D. L. Sly, and R. H. Purcell. 1980. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect. Dis. 141:590-602.
20. Rizzetto, M., G. Verme, S. Reechia, F. Bonino, P. Farci, S. Arico, R. Calzia, A. Pieciotto, M. Colombo, and H. Popper. 1983. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann. Intern. Med. 98:437-441.
21. Roingeard, P., F. Dubois, P. Marcellin, J. Bernuau, S. Bonduelle, J. P. Benhamou, and A. Goudeau. 1992. Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection. J. Med. Virol. 38:191-194.
22. Su, C. W., Y. H. Huang, T. I. Huo, H. H. Shih, I. J. Sheen, S. W. Chen, P. C. Lee, S. D. Lee, and J. C. Wu. 2006. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 130:1625-1635.
23. Taylor, J. M. 2003. Replication of human hepatitis delta virus: recent developments. Trends Microbiol. 11:185-190.
24. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77: 68-76.
25. Wang, J. G., R. W. Jansen, E. A. Brown, and S. M. Lemon. 1990. Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J. Virol. 64:1108-1116.
26. Wu, J. C., C. L. Cben, M. C. Hou, T. Z. Cben, S. D. Lee, and K. J. Lo. 1994. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology 19:836-840.
27. Wu, J. C., T. Z. Chen, Y. S. Huang, F. S. Yen, L. T. Ting, W. Y. Sheng, S. H. Tsay, and S. D. Lee. 1995. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology 108:796-802.
28. Wu, J. C., T. Y. Chiang, and I. J. Sheen. 1998. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J. Gen. Virol. 79(Pt. 5):1105-1113.
29. Wu, J. C., T. Y. Chiang, W. K. Shiue, S. Y. Wang, I. J. Sheen, Y. H. Huang, and W. J. Syu. 1999. Recombination of hepatitis D virus RNA sequences and its implications. Mol. Biol. Evol. 16:1622-1632.
30. Wu, J. C., K. B. Choo, C. M. Chen, T. Z. Chen, T. I. Huo, and S. D. Lee. 1995. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 346:939-941.
31. Yang, Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.
32. Yang, Z., and J. P. Bielawski. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15:496-503.
33. Yang, Z., R. Nielsen, N. Goldman, and A. M. Pedersen. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.